ACTL6A and neoplasm: Tumors were harvested upon reaching 1000 mm3 in the control group and endpoint measurement of tumor weight revealed similar results, with IACS-010759 treatment leading to significantly lower tumor weight only in ACTL6A-depleted tumors (fig.